Solithromycin

 

Topic mentions per year

Topic mentions per year

2010-2018
05101520102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Solithromycin, a new macrolide and the first fluoroketolide, is in late-stage clinical development and, like older macrolides, is… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2015
2015
BACKGROUND Progressive resistance to antimicrobial agents has reduced options for gonorrhea therapy worldwide. Solithromycin (CEM… (More)
Is this relevant?
2014
2014
Mycoplasma genitalium has become well established as an etiological agent of sexually transmitted infections, but due to its… (More)
Is this relevant?
2014
2014
The activity of solithromycin was evaluated against clinical Legionella pneumophila serogroup 1 (Lp1) isolates (n = 196… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Macrolides are reported to reduce exacerbation of chronic inflammatory respiratory disease, such as chronic obstructive pulmonary… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Macrolides are reported to reduce exacerbation of chronic inflammatory respiratory disease, such as chronic obstructive pulmonary… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Solithromycin, a new macrolide, and the first fluoroketolide in clinical development, with activity against macrolide-resistant… (More)
Is this relevant?
2012
2012
Gonorrhea may become untreatable, and new treatment options are essential. We investigated the in vitro activity of the first… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2011
2011
Solithromycin (CEM-101) is a novel fluoroketolide with high potency against Gram-positive and Gram-negative bacteria commonly… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2011
2011
The pharmacokinetics of orally administered solithromycin (CEM-101), a novel fluoroketolide, were evaluated in healthy subjects… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?